Weekly Recap | KALA BIO -19.05%, telehealth LOI signedWeekly Review·Oct 3, 2026 at 07:03 AMKALA-2.05%
Weekly Recap | KALA BIO -26.49%, consensus target far above spotWeekly Review·Sep 5, 2026 at 07:18 AMKALA-2.05%
